Seven UCD Research Projects Awarded Commercialisation Funding by SFIWednesday, 26 April, 2017
Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, has announced funding for seven UCD research projects, which will facilitate the commercialisation of research across a range of disciplines in science, technology, engineering and maths (STEM).
The SFI Technology Innovation Development Award (TIDA) programme is run in collaboration with Enterprise Ireland and supports researchers undertaking applied research projects that demonstrate potential for strong economic impact.
Seven research projects at UCD have been funded under this scheme in a range of areas. The research ambition for each project is significant and addresses current issues and shortcomings in areas such as diabetes management, MRSA, and ovarian cancer screening, amongst others.
Details of the seven research projects from UCD are outlined below:
|Name||School||Brief Overview of the Research Ambition|
|Prof David Brayden Dr Delyan Hristov (postdoc)||UCD School of Veterinary Medicine & UCD Conway Institute UCD School of Chemistry||This project is about trying to orally-deliver a diabetes-treating peptide drug that is normally injected twice a day by diabetic patients. It involves entrapping the drug in a particular nanoparticle designed to protect it from breakdown in the stomach and to promote its uptake by the gut wall so that it can reach its target in the body.|
|Dr Andrew Phillips||UCD School of Chemistry||Dr Phillips will work on the development of a 3-D printable antimicrobial polymer technology that incorporates antibiotics designed to prevent hospital-related infections, such as MRSA.|
|Prof Eoin Casey||UCD School of Chemical and Bioprocess Engineering||The project will develop a new purification technology that will enable more efficient large-scale production of pharmaceuticals.|
|Prof Declan Gilheany||UCD School of Chemistry & UCD Conway Institute||Prof Gilheany will develop a chemical platform that enables the design and synthesis of the emerging class of therapies known as microRNAs|
|Prof Walter Kolch||UCD School of Medicine, Systems Biology Ireland and UCD Conway Institute||Next Generation Ex-vivo Functional Predictive Assays for High Grade Serous Ovarian Cancer Screening: Three Dimensional, Multicellular Drug Screening using Lab on a Chip Technologies|
|Dr Madeline Murphy||UCD School of Medicine||Development of a novel assay for sensitive and accurate detection of early stage kidney disease via exploitation of an hypoxia inducible protein|
|Dr Margaret McGee||UCD School of Biomolecular & Biomedical Science and UCD Conway Institute||Novel Anti-Inflammatory Biotherapeutic Development|
Speaking of the Awards, Minister Mary Mitchell O’Connor said: “…this investment in research commercialisation and entrepreneurship training…will enable [researchers] to take the first steps in developing new discoveries and inventions with commercial potential.”
The SFI TIDA programme is designed to enable researchers to focus on the initial stages of an applied research project, facilitating researchers with the opportunity to demonstrate the technical feasibility of their project, directed toward the development of a new or innovative technology, product, process or service that has potential for further commercial development.